|
Aug 4
|
Earnings To Watch: Myriad Genetics (MYGN) Reports Q2 Results Tomorrow
|
|
Jul 31
|
Myriad Genetics Announces New $200 Million Credit Facility
|
|
Jul 29
|
Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025
|
|
Jul 29
|
Why Myriad Genetics (MYGN) Shares Are Falling Today
|
|
Jul 29
|
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers
|
|
Jul 18
|
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know
|
|
Jul 15
|
Myriad Genetics Earns 2025 Great Place To Work Certification™
|
|
Jul 11
|
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know
|
|
Jun 27
|
5 Revealing Analyst Questions From Myriad Genetics’s Q1 Earnings Call
|
|
May 30
|
3 Cash-Burning Stocks Facing Headwinds
|
|
May 27
|
Myriad Genetics, Inc. (MYGN) Showcases Breakthrough MRD Data and AI-Driven Cancer Tools at ASCO 2025
|
|
May 27
|
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
|
|
May 27
|
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
|
|
May 22
|
3 Small-Cap Stocks with Questionable Fundamentals
|
|
May 21
|
Spotlight On 3 Penny Stocks With Market Caps Under $500M
|
|
May 19
|
MYGN Q1 Earnings Call: Guidance Cut Amid GeneSight Challenges and Slow Hereditary Cancer Ramp
|
|
Apr 15
|
Myriad Genetics price target lowered to $9 from $11 at BofA
|
|
Apr 8
|
Myriad Genetics Announces Inducement Awards
|
|
Apr 7
|
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
|
|
Mar 12
|
Why Are Myriad Genetics (MYGN) Shares Soaring Today
|